What an exciting month or so it has been for learning about advances in psoriatic disease research. In the beginning of April, the University of Pennsylvania and the National Lung Heart and Blood Institute partnered to discuss the prevention of cardiovascular disease (CVD) in individuals with psoriasis and psoriatic arthritis (PsA). Toward the end of the month, New York University (NYU) held a day-long conference on the management of cardiometabolic risk in inflammatory conditions. The American Academy of Dermatology (AAD) Virtual Meeting Experience also occurred at the end of April. Then May brought the Society of Investigative Dermatology (SID) annual conference, at which the National Psoriasis Foundation (NPF) had a virtual session and discussed the NPF COVID-19 Task Force, as well as recent research and the impact health disparities have on care and outcomes.
With all this great information being shared, we wanted to provide you with the highlights related to psoriatic disease research from these meetings.